Paul Johnson, a successful entrepreneur with a passion for transforming traditional industries with technology, shares his remarkable journey just crystallized on a $400 million acquisition in a recent interview for the DealMakers podcast. His venture, Lemonaid Health, has attracted funding from top-tier investors like Sierra Ventures, Health Velocity Capital, Correlation Ventures, and Hikma Ventures.

The post Paul Johnson On Selling For $400 Million His Telehealth And Prescription Delivery Startup To 23andMe first appeared on Alejandro Cremades.

The post Paul Johnson On Selling For $400 Million His Telehealth And Prescription Delivery Startup To 23andMe appeared first on Alejandro Cremades.